Jacques H. Abraini

TL;DR: The available data demonstrate that dopamine and glutamate do not uniformly interact to modulate each others' release and postsynaptic modulation of striatal output neurons.

TL;DR: In this paper, the authors investigated whether nitrous oxide or xenon, which are gaseous anesthetics with a remarkably safe clinical profile that have been recently demonstrated as effective inhibitors of the NMDA receptor, may reduce the following: (1) ischemia-induced brain damage in vivo, when given after occlusion of the middle cerebral artery (MCAO), a condition needed to make these potentially neuroprotective agents therapeutically valuable; or (2) NMDA-induced Ca2+ influx in cortical cell cultures, a major critical event involved in exc

TL;DR: The hypothesis that hydrogen can alleviate some of the symptoms of the high-pressure nervous syndrome and can constitute a useful gas for commercial diving is supported, as it decreases the density of the breathing mixture and therefore improves the living conditions, work, and comfort of the divers.

TL;DR: It is shown that xenon, administered at subanesthetic doses, offers global neuroprotection from reduction of neurotransmitter release induced by ischemia, a critical event known to be involved in excitotoxicity, to reduction of subsequent cell injury and neuronal death.

TL;DR: Data indicate, in agreement with previous studies, that anxiety may favour, or at least not alter, the processes of information of relatively simple tasks, such as reaction time, and further suggest that adverse changes in moods could modulate performance negatively.